Journals / Bakırköy Tıp Dergisi / 2020 / Cilt: 16 - Sayı: 3

Comparison of Serum and Salivary Alpha-Fetoprotein Levels in Pregnancies Complicated with Neural Tube Defects

Nöral Tüp Defekti ile Komplike Gebeliklerde Serum ve Tükürük Alfa-fetoprotein Düzeylerinin Karşılaştırılması

Pages
212–217
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The intra‐, and inter- test assay coefficients (CVs) of the kit were

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To compare the serum and salivary values of alpha-fetoprotein (AFP) used in screening neural tube defects (NTD) during pregnancy.
📊
Key Findings & Data:Method: The study was conducted between May 2018 - November 2019 at Adıyaman University.
💡
Conclusion & Impact:The intra‐, and inter- test assay coefficients (CVs) of the kit were
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To compare the serum and salivary values of alpha-fetoprotein (AFP) used in screening neural tube defects (NTD) during pregnancy. To investigate whether saliva can be used instead of serum in NTD screening. Method: The study was conducted between May 2018 - November 2019 at Adıyaman University. The study included 41 pregnant women complicated by NTD and 44 healthy pregnant women. Three ml venous blood and 2 ml saliva samples were taken from both groups. Serum and saliva samples were not diluted. AFP concentration was measured at 450 nm by using commercially available enzyme-linked immunoassay. The intra‐, and inter- test assay coefficients (CVs) of the kit were

Özet

Amaç: Gebelikte nöral tüp defekti (NTD) taramasında kullanılan alfa-fetoproteinin (AFP) serum ve tükürük değerlerini karşılaştırmak. NTD taramasında serum yerine tükürük örneğinin kullanıp kullanılamayacağını araştırmak. Yöntem: Çalışma Mayıs 2018 - Kasım 2019 tarihleri arasında Adıyaman Üniversitesi’nde yapıldı. Çalışmaya gebeliği NTD ile komplike olmuş 41 gebe ve sağlıklı gebeliği olan 44 gebe dâhil edildi. Her iki grup gebelerden 3 ml venöz kan ve 2 ml tükürük örneği alındı. Serum ve tükürük numuneleri seyreltilmedi. AFP konsantrasyonu, ticari olarak temin edilebilen enzim bağlı immünolojik test kullanılarak 450 nm’de ölçüldü. Kitin intra‐ ve inter‐ test tahlil katsayısı (CV) sırasıyla

🔖

Cite This Article

BÜLBÜL, M., KARACOR, T., KIRICI, P., NACAR, M. C., ÖNDERCİ, M., PEKER, N., SAK, S. (2022). Comparison of Serum and Salivary Alpha-Fetoprotein Levels in Pregnancies Complicated with Neural Tube Defects. Bakırköy Tıp Dergisi, Cilt: 16 - Sayı: 3, 212–217. https://ajindex.com/articles/460043

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Greene ND, Copp AJ. Neural tube defects. Annu Rev Neurosci. 2014;37:221-42.
  2. Desai VR, Gadgil N, Saad S, Raskin JS, Lam SK. Measures of health-related quality of life outcomes in pediatric neurosurgery: literature review. World Neurosurg. 2019;122:252-65.
  3. Cameron M, Moran P. Prenatal screening and diagnosis of neural tube defects. Prenat Diagn. 2009;29:402-11.
  4. Brock DJH, Sutcliffe RG. Early prenatal diagnosis of anencephaly. Lancet. 1972;9:1252-3.
  5. Seller MJ, Coltart TM, Campbell S, Singer JD. Early termination of anencephalic pregnancy after detection by raised alpha-fetoprotein levels. Lancet. 1973;14:73.
  6. Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY. Alphafetoprotein decrease from > 1,000 to 7. Mancal P, Srámek M, Malbohan I, Simek L. The first clinical trial for determination of alpha 1 fetoprotein by means of Sevatest-ELISA AFP Kit (micro I). J Hyg Epidemiol Microbiol Immunol. 1988;32(2):209-17. PMID: 2457612
  7. Zhan Z, Guan Y, Mew K, Zeng W, Peng M, Hu P, et al. Urine alpha-fetoprotein and orosomucoid 1 as biomarkers of hepatitis B virus-associated hepatocellular carcinoma. Am J Physiol Gastrointest Liver Physiol. 2020;318:305-12.
  8. Kaczor-Urbanowicz KE, Carreras-Presas CM, Aro K, Tu M, Garcia-Godoy F, Wong DT. Saliva diagnostics current views and directions. Exp Biol Med. 2016;242:459-72.
  9. Szabó N, Gergev G, Valek A, Eller J, Kaizer L, Sztriha L. Birth prevalence of neural tube defects: a populationbased study in South-Eastern Hungary. Childs Nerv Syst. 2013;29:621-7.
  10. Robinson AJ, Blaser S, Toi A, Chitayat D, Halliday W, Pantazi S, et al. The fetal cerebellar vermis: assessment for abnormal development by ultrasonography and magnetic resonance imaging. Ultrasound Q. 2007;23:211-23.
  11. Fuchs KM, Peipert JF. First trimester down syndrome screening: public health implications. Semin Perinatol. 2005;29:267-71.
  12. Xiao H, Wong DT. Proteomics and its applications for biomarker discovery in Human Saliva. Bioinformation. 2011;5:294-6.
  13. Nagler R, Bahar G, Shpitze